Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,500.00
Spread: 100.00 (1.852%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Governance changes

2 Nov 2020 07:15

RNS Number : 8520D
Camellia PLC
02 November 2020
 

2 November 2020

 

Camellia Plc

Governance changes

Following allegations of serious human rights abuses at Kakuzi Plc in Kenya, Camellia has been reviewing its governance and safeguarding oversight arrangements and is setting up a Safeguarding and Stewardship Committee of Camellia's Board of Directors.

Camellia is also pushing the Boards of the companies we invest in to look at their own procedures, and where necessary make operational changes.

Camellia welcomes the news that Kakuzi has taken further steps to upgrade its governance and safeguarding measures. Details are set out in Kakuzi's announcement which is reproduced below. They include establishing an Independent Human Rights Advisory Committee and setting up an Operational-level Grievance Mechanism in line with UN Guiding Principles on Business and Human Rights.

These are important steps forward so that local communities, Kakuzi, and all those who depend upon it for their livelihoods can thrive together in the years to come.

Camellia will continue to do all it can to ensure that companies it invests in operate to the highest standards of governance.

 

Enquiries

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

KAKUZI PLC

Board changes, establishment of Independent Human Rights Advisory Committee to the Board and of an Operational-level Grievance Mechanism

 

Board changes

The Board of Kakuzi Plc is pleased to announce that Nicholas Nganga has been appointed Chairman of the Board with immediate effect. He takes over from Graham Mclean who steps down from the role but will remain a non-executive Director. Among his other roles, Nicholas Nganga was Chairman of Safaricom, Kenya's leading telecoms operator, from 2007 until 2020, and is current Chairman of Car & General Kenya Limited and G4S Security.

Dr John Kibunga Kimani has been appointed to the Board of Kakuzi Plc as a non-executive Director with effect from 1 November 2020. Dr John Kimani has extensive experience in the agricultural sector (public and private) including planning, development and administration of small-holder agricultural extension programmes at District level, developing and managing small-holder irrigation projects and preparing long-range plans for land and water resources across Kenya. Notably he led the planning team in the Tana and Athi River basins embracing six districts of what were Central, Eastern and Coast Provinces of Kenya. He has worked with Government agricultural projects aided by the World Bank, SNV of the Netherlands, JICA of Japan, DANIDA of Denmark and GTZ of Germany.

In addition to being a fellow of the Economic Development Institute of the World Bank, Dr John Kimani has a Bsc in Agriculture (Makerere University College, Uganda); an Msc in Agricultural Economics (Reading University, U.K) and a Phd in Development Studies, Economics and Socio-anthropology (University of Sussex, U.K). Dr John Kimani is a member of the Agricultural Society of Kenya as well as a member of the Avocado Exporters Association of Kenya.

 

In addition to the above, the Board agreed on the following:

Independent Human Rights Advisory Committee

To enhance governance structures within Kakuzi Plc, the Board is establishing an Independent Human Rights Advisory Committee (IHRAC). The IHRAC will comprise experienced and distinguished individuals drawn from the human rights sector locally and internationally, and representatives of our stakeholders. Andrew Ndegwa Njoroge, a non-executive independent director of Kakuzi plc, will sit on the IHRAC.

 

Operational-level Grievance Mechanism

The Board is also upgrading Kakuzi's current alternative dispute resolution process by setting up a full Operational-level Grievance Mechanism (OGM), as defined by the UN Guiding Principles on Business and Human Rights. This will enable members of the community to have their grievances heard and resolved quickly, impartially and in accordance with internationally recognized best practices. It will also ensure that appropriate action is taken to deal with anyone who fails to live up to the standards Kakuzi Plc expects of its employees.

 

Nick Nganga, Chairman of Kakuzi Plc, said:

"Kakuzi sells its produce both locally and across the world. We must always ensure our corporate policies and human rights processes evolve to accommodate feedback and input from our employees, communities and other stakeholders, wherever they are based.  The changes and initiatives announced by the Board today are important steps in this regard. Dr Kimani will be a valuable addition to the Kakuzi Board. He knows Kakuzi well having grown up on the farm. He has an impressive and well-respected track record in the agricultural sector of this country which he built up working in private and public sector enterprises and projects.  "The Independent Human Rights Advisory Committee and the Operational-level Grievance Mechanism are significant enhancements to Kakuzi's governance processes. They underscore our determination to take a 'belt and braces' approach to human rights."  

31st October 2020

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBBBMTMTBMTIM
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.